Brinker Capital’s Pfizer PFE Stock Holding History

Brinker Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$14.2M	Buy	456,911 +75,210	+20%	+$2.56M	0.45%	37
2020 Q1	$11.8M	Buy	381,701 +20,282	+6%	+$691K	0.47%	29
2019 Q4	$13.4M	Buy	361,419 +6,280	+2%	+$224K	0.42%	37
2019 Q3	$12.1M	Buy	355,139 +54,597	+18%	+$1.99M	0.42%	38
2019 Q2	$12.4M	Buy	300,542 +6,392	+2%	+$254K	0.45%	36
2019 Q1	$11.9M	Buy	294,150 +4,331	+1%	+$173K	0.45%	37
2018 Q4	$12M	Sell	289,819 -5,833	-2%	-$242K	0.53%	30
2018 Q3	$12.4M	Buy	295,652 +5,784	+2%	+$223K	0.45%	30
2018 Q2	$9.98M	Sell	289,868 -47,652	-14%	-$1.63M	0.38%	44
2018 Q1	$11.4M	Buy	337,520 +6,007	+2%	+$207K	0.45%	31
2017 Q4	$11.4M	Sell	331,513 -15,198	-4%	-$518K	0.44%	31
2017 Q3	$11.7M	Buy	346,711 +11,232	+3%	+$361K	0.49%	27
2017 Q2	$10.7M	Buy	335,479 +63,060	+23%	+$1.99M	0.49%	30
2017 Q1	$8.84M	Buy	272,419 +21,221	+8%	+$669K	0.41%	33
2016 Q4	$7.74M	Buy	251,198 +238,042	+1,809%	+$7.27M	0.43%	38
2016 Q3	$423K	Buy	+13,156	New	+$440K	0.04%	221

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brinker Capital's PFE Position: Q2 2020 in Review

Brinker Capital increased its Pfizer (PFE) stake by 20% in Q2 2020, buying an estimated $2.56M and bringing the position to 456,911 shares worth $14.2M. The position accounts for 0.45% of the portfolio, ranked #37.

Brinker Capital first reported a position in PFE in Q3 2016 and has held it in 16 quarters since. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Brinker Capital held 456,911 shares of Pfizer worth $14.2M as of Q2 2020.
Brinker Capital bought 75,210 Pfizer shares in Q2 2020, an estimated $2.56M.
Pfizer made up 0.45% of Brinker Capital's portfolio in Q2 2020, its #37 holding.
Brinker Capital first reported a position in Pfizer in Q3 2016 and has held it in 16 quarters since.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.